Editorial & Peer-Review Policy
BioScienceDesk maintains strict scientific publishing standards to ensure all laboratory protocols, equipment benchmarks, and technical guides are objective, reproducible, and verifiable.
1. The Technical Peer-Review Workflow
Every technical manuscript submitted to BioScienceDesk undergoes an initial editorial triage followed by double-blind technical assessment conducted by at least one subject matter specialist holding an advanced degree (M.Sc. or Ph.D.) in the relevant discipline.
- Reagent Validation: Chemical formulations, molarities, pH values, and incubation timings are cross-referenced with primary peer-reviewed literature (PubMed, NCBI, Nature Protocols).
- Reproducibility Audit: Standard operating procedures must specify negative and positive analytical controls, limit of detection parameters, and dynamic range constraints.
2. Commercial Independence & Advertising Demarcation
To preserve reader trust and institutional objectivity, editorial evaluations of laboratory equipment, reagents, and diagnostic CDMO facilities are conducted completely independently of commercial advertising contracts.
All sponsored resources, partner whitepapers, and promotional banners are prominently demarcated with explicit labeling (e.g., "Sponsored Resource" or "Advertisement") in full compliance with US Federal Trade Commission (FTC) and Google Publisher Guidelines.
3. Corrections & Protocol Errata Policy
Scientific precision is paramount. If an error in reagent concentration, buffer formulation, or protocol sequence is identified by our readers or reviewers, our editorial team commits to issuing an immediate correction note within 24 hours of notification.
To submit an erratum or factual correction, please email our editorial desk at editor@biosciencedesk.com with the subject line "Protocol Erratum".